Ordentlich Peter insider trades
Ordentlich Peter has filed 5 Form 4s with the SEC that we hold, all for Syndax Pharmaceuticals Inc (SNDX), as Chief Scientific Officer. Across all of them we count 0 purchases worth $0 and 9 sales worth $1.9M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 22,846 shares of Syndax Pharmaceuticals Inc worth $572.1K, dated 2022-08-24. The first filing on our record is dated 2022-02-03 and the latest 2023-02-17.
Syndax Pharmaceuticals Inc (SNDX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-01 | S, sale reported on Form 4 | 1,412 | $23.5K | 2022-02-03 |
| 2022-08-24 | S, sale reported on Form 4 | 2,154 | $53.9K | 2022-08-26 |
| 2022-08-24 | S, sale reported on Form 4 | 22,846 | $572.1K | 2022-08-26 |
| 2022-12-01 | S, sale reported on Form 4 | 4,028 | $100.7K | 2022-12-02 |
| 2022-12-01 | S, sale reported on Form 4 | 3,772 | $94.3K | 2022-12-02 |
| 2022-12-02 | S, sale reported on Form 4 | 17,200 | $430.9K | 2022-12-02 |
| 2023-02-01 | S, sale reported on Form 4 | 69 | $2.0K | 2023-02-03 |
| 2023-02-15 | S, sale reported on Form 4 | 7,572 | $195.7K | 2023-02-17 |
| 2023-02-15 | S, sale reported on Form 4 | 17,428 | $450.3K | 2023-02-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1594274) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms